Mostrando resultados 125 a 144 de 215
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | 2005 | N-terminal cleavage of proTGFα occurs at the cell surface by a TACE-independent activity | Juanes, Pedro P.; Ferreira, Laura; Montero, Juan Carlos CSIC ORCID; Arribas, Joaquín; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2014 | NADPH oxidases as therapeutic targets in chronic myelogenous leukemia | Gutiérrez-Herrero, Sara; Pandiella, Atanasio CSIC ORCID CVN ; Guerrero Arroyo, María del Carmen CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Sánchez-Guijo, Fermín M. CSIC ORCID; Cañizo, María Consuelo del; Hernández-Hernández, Ángel CSIC ORCID | artículo |
| openAccess |  | 2016 | Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies | Ocaña, Alberto; Díez-González, Laura; Esparís-Ogando, Azucena CSIC ORCID ; Montero, Juan Carlos CSIC ORCID; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2008 | Neuregulins and Cancer | Montero, Juan Carlos CSIC ORCID; Rodríguez-Barrueco, Ruth CSIC ORCID; Ocaña, Alberto; Díaz-Rodríguez, Elena CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2017 | Neutrophils in cancer: prognostic role and therapeutic strategies | Ocaña, Alberto; Nieto-Jiménez, Cristina; Pandiella, Atanasio CSIC ORCID CVN ; Templeton, Arnoud J. | artículo |
| closedAccess |  | 2008 | New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings | Ocio, Enrique M. CSIC ORCID ; Mateos, Maria Victoria; Maiso, Patricia; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2022 | Novel adcs and strategies to overcome resistance to anti-her2 adcs | Díaz-Rodríguez, Elena CSIC ORCID CVN; Gandullo-Sánchez, Lucía CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo de revisión |
| closedAccess |  | 2017 | Novel synthetic lethality approaches for drug combinations and early drug development | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2009 | Novel tyrosine kinase inhibitors in the treatment of cancer | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | oct-2021 | Ocoxin oral solution demonstrates antiviral properties in cellular models | Pandiella, Atanasio CSIC ORCID CVN ; Sanz, Eduardo; Díaz-Rodríguez, Elena CSIC ORCID CVN | artículo |
| openAccess |  | 2017 | ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA | Talamillo, Ana; Grande, Lara; Ruiz Ontañón, Patricia; Velásquez, Carlos; Mollinedo, Pilar; Aznar, Ángela; Esparís-Ogando, Azucena CSIC ORCID ; López-López, Carlos; Lafita, M. Carmen CSIC ORCID; Berciano, María T.; Montero, Juan A.; Vázquez-Barquero, Alfonso; Segura, Víctor; Villagra, Nuria T.; Pandiella, Atanasio CSIC ORCID CVN ; Lafarga, Miguel; León, Javier CSIC ORCID CVN; Martínez-Climent, José Ángel; Sanz-Moreno, Victoria; Fernández-Luna, J. L. | artículo |
| closedAccess |  | 2011 | Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs | Martínez-López, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| closedAccess |  | 2011 | Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer | Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2005 | Overexpression of RasN17 fails to neutralize endogenous ras in MCF7 breast cancer cells | Yuste, Laura CSIC; Esparís-Ogando, Azucena CSIC ORCID ; Santos de Dios, Eugenio CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2011 | P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer | Montero, Juan Carlos CSIC ORCID; Seoane, Samuel CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2019 | Paclitaxel-trastuzumab mixed nanovehicle to target HER2-overexpressing tumors | Nieto, Celia; Centa, Ariana; Rodríguez-Rodríguez, Jesús A.; Pandiella, Atanasio CSIC ORCID CVN ; Martín del Valle, Eva María | artículo |
| closedAccess |  | 2020 | PDCD4 limits prooncogenic neuregulin-ErbB signaling | Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 29-jul-2010 | Personalized therapies in the cancer "omics" era | Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer | Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2015 | Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors | Serrano-Heras, Gemma CSIC ORCID; Cuenca-López, María D.; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
